LGALS3 and metabolic dysfunction-associated steatohepatitis: Lgals3 was explored in another study that compared human serum protein levels in a larger number of healthy and NASH patients; the results showed that the levels of Lgals3 were increased, along with those of other markers, such as caspase recruitment domain and interleukin 18, with 61% accuracy (43).